Picture of Nyxoah SA logo

NYXH — Nyxoah SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Nyxoah SA reports results for the quarter ended December 31 - Earnings Summary

Nyxoah SA NYXH.BR reported a quarterly adjusted loss of 46 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -38 cents.  The mean expectation of six analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -59 cents to -33 cents per share.

Revenue fell 30.8% to €1.26 million from a year ago; analysts expected €1.96 million.

Nyxoah SA's reported EPS for the quarter was a loss of 46 cents​.

The company reported a quarterly loss of €17.15 million.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Nyxoah SA is €14.38

This summary was machine generated from LSEG data March 13 at 12:00 p.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 2024-0.46-0.46Met
Sep. 30 2024-0.47-0.50Missed
Jun. 30 2024-0.42-0.43Missed
Mar. 31 2024-0.42-0.41Beat

Recent news on Nyxoah SA

See all news